# Monoclonal antibodies: Science

Source page: https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-science/

#### Principles

The science it rests on, with why each principle matters to it
 Relies on

- [Acquired immunity and antibodies](https://www.materialinsights.org/science/acquired_immunity/) Each antibody-making cell makes one antibody fitting one target; the method captures and multiplies a single such cell's output ^[1].
- [Cell theory](https://www.materialinsights.org/science/cell_theory/) Antibodies come from living cells, and fusing two cells into one hybrid that keeps the traits of both is the core of the hybridoma technique ^[1].
 Limited by

- [Acquired immunity and antibodies](https://www.materialinsights.org/science/acquired_immunity/) The patient's own immune system can attack foreign antibodies: mouse antibodies trigger a rapid anti-mouse response ^[2].

as of 2026-11-11

#### Discoveries

The discoveries that made it possible: when, by whom and what was found

| Year | Who | What |
|---|---|---|
| 1959 | Gerald Edelman and Rodney Porter | First results on the chemical structure of antibodies, later shown to be Y-shaped molecules of two light and two heavy chains; Nobel Prize 1972 ^[4] |
| 1975 | Georges Köhler and César Milstein | The hybridoma technique for making monoclonal antibodies; Nobel Prize 1984, shared with Niels Jerne ^[1] |
| 1994 | Developers of the HuMabMouse and a second transgenic mouse line | Transgenic mouse lines that make human antibodies ^[2] |

as of 2026-11-11

#### The science explained

The science behind it explained for a curious reader

Picture the immune system as a huge locksmith's shop in which each worker cuts just one key shape. When a germ shows up, the workers whose keys fit its locks multiply and pour out keys. Normally that gives a jumble of many different keys. Köhler and Milstein found a way to take a single worker and make it immortal by fusing it with a tumour cell ^[1]. The hybrid keeps cutting the same key for ever, so you can grow as much of one exact key as you want. Pick a key that fits a lock on a cancer cell or an inflammatory protein, and you have a drug that finds that one target. The early keys were mouse-made, so the body rejected them ^[2]; engineers later rebuilt them with human parts.

as of 2026-11-11

#### Sources

1. [The Nobel Prize in Physiology or Medicine 1984: press release](https://nobelprize.org/prizes/medicine/1984/press-release) Nobel Assembly at Karolinska Institutet (nobelprize.org)
2. [Development of therapeutic antibodies for the treatment of diseases](https://pmc.ncbi.nlm.nih.gov/articles/PMC6939334) Journal of Biomedical Science 27: 1 (Lu, Hwang, Liu, Lee, Tsai, Li and Wu), on PubMed Central, 2020
3. [The Nobel Prize in Physiology or Medicine 1972 - Press release](https://www.nobelprize.org/prizes/medicine/1972/press-release/) Nobel Assembly at Karolinska Institutet (nobelprize.org), 1972

## Other sections

- [Summary](https://www.materialinsights.org/technologies/monoclonal_antibodies/index.md)
- [Overview](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-overview/index.md)
- [Evolution](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/monoclonal_antibodies/tech-industries/index.md)
